Skip to content

TALENT-Study Obesity and Diabetes risk - A randomized controlled trial to investigate the effectiveness of a lifestyle program (IHM-SEPP) on overweight and type 2 diabetes risk

TALENT-Study Obesity and Diabetes risk - A randomized controlled trial to investigate the effectiveness of a lifestyle program (IHM-SEPP) on overweight and type 2 diabetes risk - TALENT-Study Diabetes risk

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00013011
Enrollment
136
Registered
2017-10-06
Start date
2017-07-03
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E66.00 E66.01

Interventions

Group 1: Lifestyle program IHM-SEPP (Individual Health Management - Sino-European Prevention Programm): access to a web-based health portal (www.viterio.de) and join of three full-day and 10 2-hour tr

Sponsors

Klinikum rechts der Isar der Technischen Universität München
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: - Authorized insurants of the AOK-Bayern in the catchment area of the IGM-Präventionszentrum SINOCUR in Bad Kötzting: Cham, Regen, Deggendorf, Dingolfing-Landau, Freyung-Grafenau, Regensburg (east county), Schwandorf, Straubing-Bogen - body mass index (BMI): 30.0-39.9 - increased diabetes risk, defined as findrisk-score > 11 (probability of at least 17% to develop diabetes over the next 10 years) - informed consent

Exclusion criteria

Exclusion criteria: - being unable to consent for themself - insufficient skills in German language - no private access to internet - known hypertension (systolic blood pressure = 160 mmHg or diastolic blood pressure = 100 mmHg) with or without medication - known hypotension (systolic blood pressure = 70 mmHg or diastolic blood pressure = 50 mmHg) - Tedium-Measure (=Burnout Scale) = 3,20 - known diabetes mellitus (type 1 or 2) - known psychiatric disease including addiciton and eating disorder - known heart disease (like CHD, arrhythmia, valvular heart defect, cardiac insufficiency) - known gastric or duodenal ulcers - known diseases of the liver or kidneys - known diseases of the eyes (e.g. retinal detachment) - known disease of the thyroid gland or taking of thyroid hormones - known disease-related impairments preventing a participation in the lifestyle program (e.g. arthrosis) - known therapeutic conditions that are due to risiks/side effects not compatible with participation in the lifestyle program - known pregnancy (or lactation) or planned in the next year - participation in another currently cinical trial or during the last 6 months

Design outcomes

Primary

MeasureTime frame
Change in body mass index (BMI) after 12 months

Secondary

MeasureTime frame
fasting glucose, laboratory findings, bioimpedance analysis (BIA), waist circumference, blood pressure, heart rate, heart rate variability, tcm constitution, tcm diagnosis, diabetes risk (screening questionnaire findrisk), hypertension risk, metabolic syndrom index, fatty liver index, comprehensive medical history, motivation and willingness to change, life satisfaction (FLZ), Tedium Measure, psycho-vegetative test, severity of mood state in general (VAS), stresses and strains, WHO-5-well-being, cardiovascular and metabolic risk factors, self-efficacy, optimism and pessimism (SWOP), 3-level-stresstest, nutrition index, moving index, physical power, The body`s defenses, Sense of coherence (SOC-13), social support (SSS). Examinations are conducted at month 0, 3, 6, 9 and 12.

Countries

Germany

Contacts

Public ContactKristina Wifling

Kompetenzzentrum für Komplementärmedizin und Naturheilkunde (KoKoNat), Klinikum rechts der Isar der Technischen Universität München

kokonat@mri.tum.de089 7266970

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026